FdaApplication

BLA 125739

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFerring Pharmaceuticals Inc.
application_typeBLA
approval_date2022-11-30

Products (1)

ProductActive ingredientStrengthDosage form
REBYOTA—BETWEEN 1X10^8 AND 5X10^10CFUSuspension

1 product